RRM2 and familial pancreatic carcinoma: It has also been shown the anti-pancreatic cancer activity of celastrol by up-regulating DDIT3 and ATF3 and down-regulating RRM2 and MCM4 [8], however, the role of celastrol in anti-pancreatic cancer remains largely elusive.